» Articles » PMID: 36127427

Single Cell Atlas Identifies Lipid-processing and Immunomodulatory Endothelial Cells in Healthy and Malignant Breast

Abstract

Since a detailed inventory of endothelial cell (EC) heterogeneity in breast cancer (BC) is lacking, here we perform single cell RNA-sequencing of 26,515 cells (including 8433 ECs) from 9 BC patients and compare them to published EC taxonomies from lung tumors. Angiogenic ECs are phenotypically similar, while other EC subtypes are different. Predictive interactome analysis reveals known but also previously unreported receptor-ligand interactions between ECs and immune cells, suggesting an involvement of breast EC subtypes in immune responses. We also identify a capillary EC subtype (LIPEC (Lipid Processing EC)), which expresses genes involved in lipid processing that are regulated by PPAR-γ and is more abundant in peri-tumoral breast tissue. Retrospective analysis of 4648 BC patients reveals that treatment with metformin (an indirect PPAR-γ signaling activator) provides long-lasting clinical benefit and is positively associated with LIPEC abundance. Our findings warrant further exploration of this LIPEC/PPAR-γ link for BC treatment.

Citing Articles

Immunomodulation by allograft endothelial cells.

Bose S, Do V, Testini C, Jadhav S, Sailliet N, Kho A Front Transplant. 2025; 4:1518772.

PMID: 39967861 PMC: 11832486. DOI: 10.3389/frtra.2025.1518772.


Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma.

Xiang X, Tao X, Hua K, Jiang H, Ding J Commun Biol. 2025; 8(1):184.

PMID: 39910262 PMC: 11799506. DOI: 10.1038/s42003-025-07605-y.


A deep learning framework for screening of anticancer drugs at the single-cell level.

Zhang P, Wang X, Cen X, Zhang Q, Fu Y, Mei Y Natl Sci Rev. 2025; 12(2):nwae451.

PMID: 39872221 PMC: 11771446. DOI: 10.1093/nsr/nwae451.


Single-cell transcriptome analysis reveals cellular reprogramming and changes of immune cell subsets following tetramethylpyrazine treatment in LPS-induced acute lung injury.

Wu M, Wang S, Chen X, Shen L, Ding J, Jiang H PeerJ. 2025; 13():e18772.

PMID: 39822976 PMC: 11737342. DOI: 10.7717/peerj.18772.


Integrative analysis of Ewing's sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy.

He F, Xu J, Zeng F, Wang B, Yang Y, Xu J Cell Commun Signal. 2025; 23(1):23.

PMID: 39800691 PMC: 11727170. DOI: 10.1186/s12964-024-02020-y.


References
1.
Hopper J, Dite G, MacInnis R, Liao Y, Zeinomar N, Knight J . Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC). Breast Cancer Res. 2018; 20(1):132. PMC: 6215632. DOI: 10.1186/s13058-018-1056-1. View

2.
Benoot T, Piccioni E, De Ridder K, Goyvaerts C . TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?. Int J Mol Sci. 2021; 22(16). PMC: 8395431. DOI: 10.3390/ijms22168691. View

3.
Lapenna A, de Palma M, Lewis C . Perivascular macrophages in health and disease. Nat Rev Immunol. 2018; 18(11):689-702. DOI: 10.1038/s41577-018-0056-9. View

4.
Welte S, Kuttruff S, Waldhauer I, Steinle A . Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol. 2006; 7(12):1334-42. DOI: 10.1038/ni1402. View

5.
Jackson H, Fischer J, Zanotelli V, Ali H, Mechera R, Soysal S . The single-cell pathology landscape of breast cancer. Nature. 2020; 578(7796):615-620. DOI: 10.1038/s41586-019-1876-x. View